Last CNY24.39 CNY
Change Today +0.12 / 0.49%
Volume 3.3M
002022 On Other Exchanges
As of 9:35 PM 02/1/15 All times are local (Market data is delayed by at least 15 minutes).

shanghai kehua bio-enginee-a (002022) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/15/14 - CNY28.60
52 Week Low
05/19/14 - CNY18.98
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI KEHUA BIO-ENGINEE-A (002022)

Related News

No related news articles were found.

shanghai kehua bio-enginee-a (002022) Related Businessweek News

No Related Businessweek News Found

shanghai kehua bio-enginee-a (002022) Details

Shanghai Kehua Bio-engineering Co., Ltd develops, manufactures, and markets in vitro diagnostic products in the People’s Republic of China and internationally. The company operates in three segments: Diagnostic Reagents, Diagnostic Laboratory Instruments, and Evacuated Receptacles. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits; and lab-instruments comprising chemistry analyzers, microplate washer/readers, electrolyte analyzers, and nucleic acid extractors. The company also offers evacuated receptacle products, including automatic de-capping centrifuges, blood collection tubes, and urine collection systems. It offers its products through a network of distributors. The company was founded in 1981 and is based in Shanghai, the People’s Republic of China.

Founded in 1981

shanghai kehua bio-enginee-a (002022) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai kehua bio-enginee-a (002022) Key Developments

Shanghai Kehua Bio-engineering Co., Ltd to Report Q3, 2014 Results on Oct 28, 2014

Shanghai Kehua Bio-engineering Co., Ltd announced that they will report Q3, 2014 results on Oct 28, 2014

Shanghai Kehua Bio-Engineering Co., Ltd Reports Unaudited Earnings Results for the Half Year Ended June 30, 2014

Shanghai Kehua Bio-engineering Co. Ltd. reported unaudited earnings results for the half year ended June 30, 2014. For the period, the company reported revenue and net profit amounted RMB 602 million and RMB 156 million, which represented increases of 13.31% and 5.08%, respectively, compared with the first half of 2012. The first half 2013 earnings per share was RMB 0.3156.

Shanghai Kehua Bio-engineering Co., Ltd to Report First Half, 2014 Results on Aug 22, 2014

Shanghai Kehua Bio-engineering Co., Ltd announced that they will report first half, 2014 results on Aug 22, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002022:CH CNY24.39 CNY +0.12

002022 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002022.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002022 Industry Range
Price/Earnings 40.3x
Price/Sales 9.7x
Price/Book 9.7x
Price/Cash Flow 40.3x
TEV/Sales 9.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI KEHUA BIO-ENGINEE-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at